Pharmaceutical

University of Toronto study advances tRNA approach for ...

Researchers show engineered tRNA can restore full-length protein production in ...

FDA grants RPDD to ReviR’s RTX-117 for CMT

The designation covers CMT as a whole and is not restricted to specific subtypes...

ViiV Healthcare’s Tivicay PD gains FDA approval for pae...

The therapy is indicated for children who are either new to treatment or have pr...

Aragen Life Sciences files DRHP with SEBI for ₹800 cror...

IPO comprises a fresh issue of ₹800 crore and an offer for sale of up to 27,329...

Jagat Pharma expands nutra portfolio with six wellness ...

The range includes Marine Collagen, L-Arginine, BeatsWell, OsteoBalance, Maxx B...

Jazz secures FDA approval for Ziihera in advanced HER2+...

The regimens include Ziihera combined with Tevimbra (tislelizumab-jsgr) and fluo...

McKesson to acquire Precision Medicine Group for $2.25bn

McKesson believes that the deal will support its clinical research and biopharma...

CBN and PHARMEXCIL sign MoU to regulate controlled subs...

The Central Bureau of Narcotics (CBN), Department of Revenue, Ministry of Finan...

Piramal Pharma strengthens future ready operations with...

Piramal Pharma, a leading global pharmaceuticals company, released its Sustaina...

Aurigene enters into long-term manufacturing, supply pa...

Aurigene Pharmaceutical Services (“Aurigene”), a wholly owned subsidiary of Dr....

Aurigene enters long-term manufacturing and supply part...

The counterparty's name has not been disclosed in view of confidentiality oblig...

Takeda’s Orzeyful secured Japan MHLW approval for narco...

This decision makes Orzeyful the only treatment in Japan currently indicated to ...

Lundbeck’s asedebart receives EC orphan designation in ...

This regulatory status is designed for therapies targeting rare, life-threatenin...

BITS Pilani Goa researchers develop pharma polymer-base...

Study demonstrate a single, affordable hydrogel for tissue engineering and 3D-p...

India Pharma Archives launched at IIM Ahmedabad

Developed by IIM Ahmedabad Archives and supported by the Indian Pharmaceutical ...

Johnson & Johnson’s multiple myeloma treatment secures ...

This decision provides a new therapeutic option for patients who have received a...